Regulation of a distinct activated RIPK1 intermediate bridging complex I and complex II in TNFα-mediated apoptosis
出版年份 2018 全文链接
标题
Regulation of a distinct activated RIPK1 intermediate bridging complex I and complex II in TNFα-mediated apoptosis
作者
关键词
-
出版物
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 115, Issue 26, Pages E5944-E5953
出版商
Proceedings of the National Academy of Sciences
发表日期
2018-06-12
DOI
10.1073/pnas.1806973115
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Intracellular regulation of TNF activity in health and disease
- (2018) Eugene Varfolomeev et al. CYTOKINE
- Ubiquitin-Mediated Regulation of RIPK1 Kinase Activity Independent of IKK and MK2
- (2018) Alessandro Annibaldi et al. MOLECULAR CELL
- A motif within the armadillo repeat of Parkinson’s-linked LRRK2 interacts with FADD to hijack the extrinsic death pathway
- (2018) Nasia Antoniou et al. Scientific Reports
- Targeting LRRK2 in Parkinson’s disease: an update on recent developments
- (2017) Sharon L. Chan et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- SPATA2 regulates the activation of RIPK1 by modulating linear ubiquitination
- (2017) Ran Wei et al. GENES & DEVELOPMENT
- MK2 Phosphorylates RIPK1 to Prevent TNF-Induced Cell Death
- (2017) Isabel Jaco et al. MOLECULAR CELL
- MK2 phosphorylation of RIPK1 regulates TNF-mediated cell death
- (2017) Yves Dondelinger et al. NATURE CELL BIOLOGY
- Necroptosis activation in Alzheimer's disease
- (2017) Antonella Caccamo et al. NATURE NEUROSCIENCE
- RIPK1 mediates a disease-associated microglial response in Alzheimer’s disease
- (2017) Dimitry Ofengeim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis
- (2017) Jiefei Geng et al. Nature Communications
- 661W is a retinal ganglion precursor-like cell line in which glaucoma-associated optineurin mutants induce cell death selectively
- (2017) Zuberwasim Sayyad et al. Scientific Reports
- NEK1mutations in familial amyotrophic lateral sclerosis
- (2016) David Brenner et al. BRAIN
- The E3 Ubiquitin Ligase c-Cbl Inhibits Microglia-Mediated CNS Inflammation by Regulating PI3K/Akt/NF-κB Pathway
- (2016) Lin Dong et al. CNS Neuroscience & Therapeutics
- NEMO Prevents RIP Kinase 1-Mediated Epithelial Cell Death and Chronic Intestinal Inflammation by NF-κB-Dependent and -Independent Functions
- (2016) Katerina Vlantis et al. IMMUNITY
- DNA-Encoded Library Screening Identifies Benzo[b][1,4]oxazepin-4-ones as Highly Potent and Monoselective Receptor Interacting Protein 1 Kinase Inhibitors
- (2016) Philip A. Harris et al. JOURNAL OF MEDICINAL CHEMISTRY
- NEK1 variants confer susceptibility to amyotrophic lateral sclerosis
- (2016) Kevin P Kenna et al. NATURE GENETICS
- RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS
- (2016) Yasushi Ito et al. SCIENCE
- More to Life than NF-κB in TNFR1 Signaling
- (2016) Adrian T. Ting et al. TRENDS IN IMMUNOLOGY
- NEMO Prevents Steatohepatitis and Hepatocellular Carcinoma by Inhibiting RIPK1 Kinase Activity-Mediated Hepatocyte Apoptosis
- (2015) Vangelis Kondylis et al. CANCER CELL
- NF-κB-Independent Role of IKKα/IKKβ in Preventing RIPK1 Kinase-Dependent Apoptotic and Necroptotic Cell Death during TNF Signaling
- (2015) Yves Dondelinger et al. MOLECULAR CELL
- Spatiotemporal regulation of the anaphase-promoting complex in mitosis
- (2015) Sushama Sivakumar et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Activation of Necroptosis in Multiple Sclerosis
- (2015) Dimitry Ofengeim et al. Cell Reports
- Insights into the anaphase-promoting complex: a molecular machine that regulates mitosis
- (2014) Leifu Chang et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Cutting Edge: RIP1 Kinase Activity Is Dispensable for Normal Development but Is a Key Regulator of Inflammation in SHARPIN-Deficient Mice
- (2014) S. B. Berger et al. JOURNAL OF IMMUNOLOGY
- LRRK2 pathobiology in Parkinson's disease
- (2014) Ian Martin et al. JOURNAL OF NEUROCHEMISTRY
- An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex
- (2014) Y. Zhang et al. JOURNAL OF NEUROSCIENCE
- RIPK3 contributes to TNFR1-mediated RIPK1 kinase-dependent apoptosis in conditions of cIAP1/2 depletion or TAK1 kinase inhibition
- (2013) Y Dondelinger et al. CELL DEATH AND DIFFERENTIATION
- The RIP1/RIP3 Necrosome Forms a Functional Amyloid Signaling Complex Required for Programmed Necrosis
- (2012) Jixi Li et al. CELL
- TAK1 Is Essential for Osteoclast Differentiation and Is an Important Modulator of Cell Death by Apoptosis and Necroptosis
- (2012) Betty Lamothe et al. MOLECULAR AND CELLULAR BIOLOGY
- NEMO Inhibits Programmed Necrosis in an NFκB-Independent Manner by Restraining RIP1
- (2012) Marie Anne O’Donnell et al. PLoS One
- The Prevalence of TNFα-Induced Necrosis over Apoptosis Is Determined by TAK1-RIP1 Interplay
- (2011) Seda Çöl Arslan et al. PLoS One
- Pannexin 1 channels mediate ‘find-me’ signal release and membrane permeability during apoptosis
- (2010) Faraaz B. Chekeni et al. NATURE
- NEMO/IKKγ regulates an early NF-κB-independent cell-death checkpoint during TNF signaling
- (2009) D Legarda-Addison et al. CELL DEATH AND DIFFERENTIATION
- The Parkinson Disease Protein Leucine-Rich Repeat Kinase 2 Transduces Death Signals via Fas-Associated Protein with Death Domain and Caspase-8 in a Cellular Model of Neurodegeneration
- (2009) C. C.-Y. Ho et al. JOURNAL OF NEUROSCIENCE
- TNF-α Induces Two Distinct Caspase-8 Activation Pathways
- (2008) Lai Wang et al. CELL
- cIAP1 and cIAP2 Facilitate Cancer Cell Survival by Functioning as E3 Ligases that Promote RIP1 Ubiquitination
- (2008) Mathieu J.M. Bertrand et al. MOLECULAR CELL
- Identification of RIP1 kinase as a specific cellular target of necrostatins
- (2008) Alexei Degterev et al. Nature Chemical Biology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started